Target Name: ZMYM2
NCBI ID: G7750
Review Report on ZMYM2 Target / Biomarker Content of Review Report on ZMYM2 Target / Biomarker
ZMYM2
Other Name(s): SCLL | Fused in myeloproliferative disorders protein | Zinc finger protein 198 | zinc finger, MYM-type 2 | zinc finger MYM-type containing 2 | ZMYM2 variant 1 | ZMYM2_HUMAN | zinc finger protein 198 | fused in myeloproliferative disorders protein | ZNF198 | Rearranged in an atypical myeloproliferative disorder | Rearranged in atypical myeloproliferative disorder protein | FIM | rearranged in an atypical myeloproliferative disorder | RAMP | Zinc finger MYM-type protein 2 | NECRC | OTTHUMP00000018086 | Zinc finger MYM-type protein 2 (isoform 1) | MYM | OTTHUMP00000018088 | Zinc finger MYM-type containing 2, transcript variant 1

Study of ZMYM2: Protein Regulator and Drug Target

ZMYM2 (Z-myristoyl-L-tryptophan-2-carboxylic acid) is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and muscle. It is a key regulator of cell signaling, and its levels have been linked to a number of diseases, including cancer, neurodegenerative diseases, and metabolic disorders.

One of the key functions of ZMYM2 is its role as a scaffold protein, which means it provides a framework for the structure and stability of other proteins. This is important because many diseases are caused by the dysfunction of normal proteins that become abnormally active or misfolded. By acting as a scaffold, ZMYM2 helps to ensure that other proteins are properly structured and remain in their functional forms.

Another important function of ZMYM2 is its role as a signaling molecule. It is involved in a number of signaling pathways that are important for cell growth, differentiation, and survival. For example, ZMYM2 has been shown to be involved in the regulation of cell proliferation, and it has been linked to the development of cancer.

In addition to its role as a signaling molecule, ZMYM2 is also a potential drug target. Its unique structure and its involvement in a number of important signaling pathways make it an attractive target for small molecules. Many studies have identified potential small molecules that can interact with ZMYM2 and modulate its activity. These small molecules include compounds that can inhibit the activity of ZMYM2, as well as those that can activate its activity.

One of the challenges in studying ZMYM2 is its complex structure. Because it is a protein that is expressed in many different tissues, it is difficult to study in isolation. To study ZMYM2, researchers have used a variety of techniques, including biochemical, cellular, and structural studies. These studies have provided valuable insights into the structure and function of ZMYM2, and have identified a number of potential drug targets.

In addition to its potential as a drug target, ZMYM2 is also an important biomarker for a number of diseases. Its levels are often elevated in tissues of diseases, such as cancer, neurodegenerative diseases, and metabolic disorders. This makes it a promising target for diagnostic tests and therapies.

Overall, ZMYM2 is a protein that is widely studied for its role in cell signaling and its potential as a drug target. Its unique structure and its involvement in a number of important signaling pathways make it an attractive target for small molecules. Further research is needed to fully understand its function and its potential as a therapeutic agent.

Protein Name: Zinc Finger MYM-type Containing 2

Functions: Involved in the negative regulation of transcription

The "ZMYM2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZMYM2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZMYM3 | ZMYM4 | ZMYM4-AS1 | ZMYM5 | ZMYM6 | ZMYND10 | ZMYND11 | ZMYND12 | ZMYND15 | ZMYND19 | ZMYND8 | ZNF10 | ZNF100 | ZNF101 | ZNF106 | ZNF107 | ZNF112 | ZNF114 | ZNF117 | ZNF12 | ZNF121 | ZNF124 | ZNF131 | ZNF132 | ZNF133 | ZNF134 | ZNF135 | ZNF136 | ZNF137P | ZNF138 | ZNF14 | ZNF140 | ZNF141 | ZNF142 | ZNF143 | ZNF146 | ZNF148 | ZNF154 | ZNF155 | ZNF157 | ZNF16 | ZNF160 | ZNF165 | ZNF169 | ZNF17 | ZNF174 | ZNF175 | ZNF177 | ZNF18 | ZNF180 | ZNF181 | ZNF182 | ZNF184 | ZNF185 | ZNF189 | ZNF19 | ZNF195 | ZNF197 | ZNF2 | ZNF20 | ZNF200 | ZNF202 | ZNF204P | ZNF205 | ZNF205-AS1 | ZNF207 | ZNF208 | ZNF209P | ZNF211 | ZNF212 | ZNF213 | ZNF213-AS1 | ZNF214 | ZNF215 | ZNF217 | ZNF219 | ZNF22 | ZNF22-AS1 | ZNF221 | ZNF222 | ZNF223 | ZNF224 | ZNF225 | ZNF225-AS1 | ZNF226 | ZNF227 | ZNF229 | ZNF23 | ZNF230 | ZNF232 | ZNF232-AS1 | ZNF233 | ZNF234 | ZNF235 | ZNF236 | ZNF236-DT | ZNF239 | ZNF24 | ZNF248 | ZNF25